Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjects. [electronic resource]
- Antimicrobial agents and chemotherapy Jul 2013
- 3194-201 p. digital
Publication Type: Clinical Trial; Journal Article
1098-6596
10.1128/AAC.02430-12 doi
Administration, Oral Adult Anti-Bacterial Agents--blood Azithromycin--blood Half-Life Humans Leukocytes, Mononuclear--drug effects Male Middle Aged Neutrophils--drug effects Plasma Young Adult